Navigation Links
Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking
Date:5/23/2008

18 years of age or older, with a valid certification. Pilots and air traffic controllers meeting the aforementioned criteria can call 1.877.NO.ASHES, or 1.877.662.7437 to request one free 48 count of 2mg or 4mg Cherry Commit lozenges, and also gain access to smoking cessation counselors. The line is open from 8 a.m. - 9 p.m. EDT, Monday through Friday (no weekends or holidays). During Memorial Day weekend, the line will be open from 12-4 p.m. EDT, Saturday and Sunday. GlaxoSmithKline Consumer Healthcare will also pay shipping and handling costs.

Smoking remains one of the leading causes of preventable death and disease and one of the most powerful and important addictions to break. That said, many smokers can't do it alone. Evidence-based treatments such as NRT, including the Commit lozenge, in combination with counseling offer a better chance of quitting versus cold turkey(2). More than 110 studies involving approximately 40,000 smokers have demonstrated the safety of NRT even in populations with specific health conditions, such as diabetes, high blood pressure, lung disease, and existing heart disease(3).

About The Give-Away

GSK Consumer Healthcare is offering to help pilots interested in quitting get started on a path to a smoke-free life. The give-away begins on Friday, May 23rd and goes through Monday, June 30th. All U.S. residents, 18 years of age or older, with a valid pilot certification are eligible. The offer is on a first come, first serve basis while supplies last. Pilots meeting the aforementioned criteria can call 1.877.NOASHES, or 1.877.662.7437. The line is open from 8 a.m. - 9 p.m. EDT, Monday through Friday (no weekends or holidays). During Memorial Day weekend, the line will be open from 12-4 p.m. EDT, Saturday and Sunday. A 48 count of 2mg or 4mg Cherry Commit lozenges is being offered as part of this promotion (subject to change without notice). Each person will have access to smoking cessation counselors through 1.877.NO.A
'/>"/>

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Video: Nutrition Comes to NASCAR
2. Video: Circulatory Care of New Jersey
3. Video: GEN Video Hits Home with Web Audience
4. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
5. Video: Food Expert B. Smith to Provide Healthy Menu Makeovers
6. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
7. Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk
8. Video: Trinity Mother Frances Neurosurgeon First in Region to Remove Brain Tumor Using Unique Surgical Procedure
9. Video: Holiday Safety Is Important
10. Video: Grin Big With an Award-Winning Smile
11. Video: BSP Pharma Inc. Announces Groundbreaking Findings from The Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2008)...a quick fix without losing taste, experts say , ...u can eat healthier this holiday season by alterin...s with the Texas AgriLife Extension Service. ,...ontent of almost any holiday recipe without a noti...ary Bielamowicz said in a news release. , "If ...
(Date:11/21/2008)...man, fresh from basic training and now serving ove...se life he saved by donating his rare blood type. ...ic of Korea (PRWEB) November 21, 2008 -- A local K...onation saved her life, met for the first time whe..., , ,Airman Tamarias Pope, 8th Security Forces Squ...
(Date:11/21/2008)...for preterm labor , , FRIDAY, Nov. 21 (H...e switch that activates the uterine muscles for co...ad to therapies for preterm labor. , The molec...the surface of these uterine muscle cells, keeping...But researchers from Dartmouth Medical School in N...
(Date:11/21/2008)... be held on January 8, 2009 , , TORONTO, No...onal Inc. ("MedEmerg") (OTCBB: MDER), one of Canad...d today that it has obtained an interim order from...its previously announced plan of arrangement (the ...Inc. ("AIM") will acquire all of MedEmerg,s outsta...
Breaking Medicine News(10 mins):Health News:Substitutions Make Holiday Fare Healthier 2Health News:Life-Saving Airman, Leukemia Patient Meet for First Time 2Health News:Life-Saving Airman, Leukemia Patient Meet for First Time 3Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3
...) is one of the most common behavioral disorders i...be to blame for some ODD cases. Researchers in, O...e diagnosed with a migraine condition. //Participa...rther evaluated during a psychological interview. ...
Stem cells are the basic building blocks of animals, forming in the new embryo and later developing into the various organs and tissues as the fetus grows. The work is very preliminary, and was done
...anned Parenthood clinic two weeks ago to quietly c...ady for. One week later, the 18-year-old lay dying...ications after she took the abortion pill. Patters...ate surrounding RU-486, the pill approved by the F...
...n relief for women during childbirth. A study don...uce the sensation of labour pain and delay the emo...he study included two groups of women, aged 20 to ...Women in one group chose from among five types of ...
Other Medicine News:Health News:Teen dies after complications from abortion pill 2
(Date:11/21/2008)...nd, November 21 , ...mmittee for Medicinal Products for Human Use (CHMP... the approval of Enbrel(R),(etanercept) as a trea...escents with severe plaque psoriasis. If approved ...ee,s recommendation, Enbrel will become the,first...
(Date:11/20/2008)... , PHILADELPHIA, Nov. 20 /PRNewswire-FirstCall... that the United States Food and Drug Administrati...(R) (eltrombopag) for the treatment of thrombocyto... thrombocytopenic purpura (ITP) who have had an in...ulins or splenectomy. The approval is a significan...
(Date:11/20/2008)... Nov. 20 Duska Therapeut...today that it has submitted its,pivotal Phase 3 A...pecial,Protocol Assessment (SPA) procedure with t... Subject to securing an agreement with the FDA,... double-blind, placebo-controlled and randomized P...
(Date:11/19/2008)...v. 19 Posit Science Corporation,r...ociety for Neuroscience,Annual Conference in Wash...aining may benefit Baby Boomers. The computerized...) uses adaptive exercises that target auditory and... drive generalized,improvements in cognition by i...
Breaking Medicine Technology:CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 2CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 3CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 4CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Immigrants From India Pakistan Face U S Prostate Breast Cancer Risks 2974 1Immigrants From India Pakistan Face U S Prostate Breast Cancer Risks 2974 2Extra payments to Medicare Advantage plans to total 248 5 billion in 2008 26084 1Extra payments to Medicare Advantage plans to total 248 5 billion in 2008 26084 2ISU researchers help map first plant parasitic nematode genome sequence 4736 1ISU researchers help map first plant parasitic nematode genome sequence 4736 2Zimmer Holdings Inc Announces Agreement to Acquire Abbott Spine an Innovator in Spinal Technology 7493 1Zimmer Holdings Inc Announces Agreement to Acquire Abbott Spine an Innovator in Spinal Technology 7493 2Zimmer Holdings Inc Announces Agreement to Acquire Abbott Spine an Innovator in Spinal Technology 7493 3Zimmer Holdings Inc Announces Agreement to Acquire Abbott Spine an Innovator in Spinal Technology 7493 4
...March 8, 2007--The World Health Organization,has r... rising in,Pakistan. , So is this another instance...armaceutical industry is denying important vaccine...rding to London’s Guardian,newspaper, &ldquo...efused to allow health workers to administer polio...
...USINESS WIRE)--Mar 8, 2007 - Magen BioSciences,In...ed the,publication of a paper in the March 9, 2007...oard member, David E. Fisher, M.D.,Ph.D., that id...n,p53, in the pigmentation of skin. Fisher,s stud...r suppressor in other cancers in,the body, p53 als...
Other Medicine Technology:Why Is Polio Spreading in Pakistan? 2Study in Cell by Magen BioSciences Co-Founder David E. Fisher,Identifies New Roles in Skin Cancer Prevention for Key Tumor,Suppressor Protein 2
Hartman Rongeurs
Echlin Duckbill Bone Rongeurs
Blumenthal Bone Rongeur
Biffer Bone Rongeur
Medicine Products: